Rosuvastatin 20 mg/day

DRUG3 trials

Sponsors

Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba, King Edward Medical University, Shiraz University of Medical Sciences

Conditions

Acute Coronary SyndromesAnthracycline Related Cardiotoxicity in Breast CancerAnthracycline-induced Cardiac ToxicityAnthracycline-induced CardiotoxicityBreast CancerHIV-1 Infection

Phase 2

Rosuvastatin to Decrease Residual Immune Activation in HIV Infection

Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'BaHIV-1 Infection

Start: 2012-03-31End: 2013-09-30Target: 40Updated: 2013-06-12

Phase 4

Impact of Atorvastatin Versus Rosuvastatin on 25 Hydroxy Vitamin D Levels in Patients With Acute Coronary Syndrome

RecruitingNCT06765265

King Edward Medical UniversityAcute Coronary Syndromes

Start: 2025-01-05End: 2026-01-01Target: 152Updated: 2025-03-11

Rosuvastatin for Prevention of Anthracycline-induced Cardiac Dysfunction in Breast Cancer Patients

Not yet recruitingNCT07254221

Shiraz University of Medical SciencesAnthracycline-induced Cardiac Toxicity, Anthracycline-induced Cardiotoxicity, Anthracycline Related Cardiotoxicity in Breast Cancer +1

Start: 2026-02-01End: 2028-04-21Target: 400Updated: 2025-12-10